68 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 60 of 68 clinical reviews.
A deep-dive into ARA 290 (cibinetide), a non-hematopoietic erythropoietin peptide fragment studied for neuropathic pain, inflammation, and metabolic repair. Includes trial data, dosing context, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
A guide covering US peptide legality, FDA status, compounding rules, drug testing, injection technique, oral bioavailability, and cycling protocols with primary-source citations.
A guide to BPC-157 for gut healing, covering mechanisms, dosing, comparisons with thymosin alpha-1, thymulin, larazotide, and KPV, plus real trial data and clinical context.
A breakdown of BPC-157 fragments, their proposed mechanism of action, comparison with TB-500/Ac-SDKP, GHRP-2 vs GHRP-6, and how regenerative peptide stacks are assembled, along with what the evidence does and does not support.
A clinical comparison of BPC-157 and TB-500 covering mechanisms, the state of the human and animal evidence, dosing patterns reported in research literature, stacking, and regulatory status.
Most peptides are destroyed in the gut before reaching the bloodstream. Learn which peptides can be taken orally, which require injection, and what the science says about absorption, legality, and safety.
A guide to the five most-studied neurotropic peptides: cerebrolysin, semax, selank, dihexa, and pinealon. Covers mechanisms, clinical evidence, dosing, safety, and how to tell which patients may benefit.
A guide to cosmetic peptides beyond GHK-Cu, covering argireline, matrixyl, SNAP-8, and topical dermorphin analogues. Includes real trial data, dosing, and how each peptide works mechanistically.
A head-to-head clinical comparison of eight cosmetic and specialty peptides, including BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin, with dosing, mechanisms, safety profiles, and guidance on which to choose.
A deep-dive into davunetide (NAP/AL-108/AL-208), covering its mechanism of action, clinical trial data from PSP and AD studies, dosing, safety, and how it compares with semax, selank, cerebrolysin, and dihexa for neuroprotection.
A clinical deep-dive into dermorphin topical applications, argireline, Matrixyl, SNAP-8, and copper peptides beyond GHK-Cu. Evidence-based guidance on doses, mechanisms, and what to realistically expect.
A clinical deep-dive into dihexa, covering mechanism of action, research data, comparisons with semax, selank, cerebrolysin, and pinealon, dosing ranges used in trials, and safety considerations reviewed by HealthRX.com physicians.
A breakdown of four specialty peptides, DSIP, PT-141 (bremelanotide), kisspeptin-10, and oxytocin, covering mechanisms, dosing, evidence, and clinical use cases.
A guide to getting Epitalon online: candidacy, typical cost, the telehealth prescription process, and an honest look at the evidence behind this investigational peptide.
A guide to five longevity peptides, covering mechanisms, clinical and preclinical evidence, dosing data, regulatory status, and how to evaluate them safely.
A guide to FDA 503A compounded peptides covering legal status, purity standards, sterility testing, storage stability, and how they differ from unregulated research peptides.
FDA sterility testing requires USP <71> sterility, endotoxin, and potency tests under 503A/503B before release, rules research chemical peptides skip entirely.
A guide to FOXO4-DRI, covering its mechanism, the 2017 mouse data, human evidence gaps, safety unknowns, and how it compares with epitalon, MOTS-c, SS-31, and humanin.
GHRP-2 raises GH about 25-50% more than GHRP-6 but causes less hunger; GHRP-6 stimulates strong appetite fast. Compare potency, cortisol effects, and uses.
A clinical comparison of GHRP-2 and ipamorelin covering mechanism, dosing, side-effect profiles, and how each fits into a broader peptide stack including BPC-157, TB-500, IGF-1 LR3, Semax, Selank, and Epitalon.
A guide to hexarelin, covering its mechanism, clinical evidence, dosing protocols, safety data, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
A clinically grounded review of HGH Fragment 176-191 (AOD 9604), covering mechanism, fat-loss data, dosing, side effects, melanotan comparisons, and myostatin inhibitor context, prepared by the HealthRX.com Editorial Team.
A guide to humanin, covering its mechanism, reported benefits, dosing data from published trials, comparisons with epitalon, MOTS-c, SS-31, and FOXO4-DRI, and what the current FDA regulatory landscape means for patients.
A guide to IGF-1 DES: how it differs from IGF-1 LR3, what the receptor-binding data show, realistic dosing windows, and when a prescriber might consider it.
A comprehensive clinical guide to IGF-1 LR3, covering its molecular mechanism, differences from native IGF-1 and IGF-1 DES, IGFBP modulation, MGF comparison, dosing protocols, and the current evidence base with primary-source citations.
IGF-1 LR3 and DES are unapproved research chemicals with no human trials. Learn how they differ from mecasermin, the only FDA-approved IGF-1 drug.
A guide to IGF-1, IGF-1 LR3, IGF-1 DES, MGF, and the binding-protein system that gates their activity. Includes mechanism context, dosing considerations, and safety boundaries pending qualified medical review.
A guide to building an immune peptide stack. Covers thymosin alpha-1, thymulin, KPV, and larazotide with doses, trial data, safety, and how each peptide fits a specific immune target.
A guide to kisspeptin 10, covering its mechanism, dosing, evidence base, and comparison with PT-141 (bremelanotide), therapeutic oxytocin, and DSIP. Includes real trial data and prescriber guidance.
A guide to KPV and systemic immune peptides, including thymosin alpha-1, thymulin, and larazotide. Covers mechanisms, dosing evidence, regulatory status, and stacking considerations.
A deep dive into larazotide, thymosin alpha-1, KPV, and thymulin: how each peptide works, what the human trial data actually show, dosing ranges used in practice, and how clinicians are beginning to stack them.
A guide to the LF-15 Camel peptide stack, covering thymosin alpha-1, thymulin, larazotide, and KPV systemic. Includes mechanisms, dosing protocols, clinical trial data, and regulatory status.
A guide to longevity peptide stacks, covering Epitalon, MOTS-C, SS-31, and Humanin: mechanisms, clinical evidence, dosing protocols, and safety considerations.
A guide to topical peptides for skin aging, covering Matrixyl (palmitoyl pentapeptide-4), Argireline (acetyl hexapeptide-3), SNAP-8, GHK-Cu, and emerging compounds. Includes trial data, doses, and practical protocol guidance.
A clinical breakdown of Melanotan 1 (afamelanotide), its FDA-designated status, melanocortin receptor mechanism, real trial data, and how it compares to AOD 9604, HGH Frag 176-191, Melanotan 2, and experimental myostatin inhibitors.
A clinical review of melanotan 2 risks, covering cardiovascular effects, melanoma risk, nausea, and comparisons with AOD 9604, HGH Frag 176-191, melanotan 1, and myostatin inhibitors. prepared by the HealthRX.com Editorial Team.
A guide to melatonin and cosmetic peptides for skin aging, covering argireline, matrixyl, SNAP-8, GHK-Cu, and emerging copper peptide variants with real trial data and dosing context.
A guide to MGF mechano growth factor, its relationship to IGF-1 splice variants, IGF-1 LR3, IGF-1 Des, and IGFBP modulation, with full citations to primary research.
A clear, evidence-graded guide to getting MOTS-c through telehealth: what the peptide is, what the 2015 Cell Metabolism study actually showed, realistic cost, and how a prescriber decides if it fits you.
A guide to mitochondrial and longevity peptides including MOTS-c, Epitalon, SS-31, Humanin, and FOXO4-DRI. Covers mechanisms, clinical and preclinical evidence, dosing, safety, and regulatory status.
Myostatin inhibitors block the protein that limits muscle growth, but no myostatin-targeting drug is FDA-approved for muscle building in healthy adults.
A guide to N-acetyl epitalon, covering its telomere biology, comparison with standard epitalon, regenerative peptide stacks including BPC-157 and TB-500 fragments, GHRP-2 vs GHRP-6 dosing, and current evidence gaps.
Separate N-Acetyl Semax claims from plain Semax research, including questions about acetylation, brain exposure, cognitive effects, and formulation stability.
A overview of the leading nootropic peptides, including Semax, Selank, Cerebrolysin, and Dihexa. Covers mechanisms, doses, trial data, safety profiles, and prescribing considerations.
A guide to therapeutic oxytocin covering intranasal use, anxiety and autism research, and how it differs from PT-141 (bremelanotide), kisspeptin-10, and DSIP.
A guide to P21 peptide covering its mechanism, comparison with Semax, Selank, Cerebrolysin, and Dihexa, the current evidence base, dosing concepts, and safety considerations.
A guide to PE-22-28, covering its mechanism as a TREK-1 potassium channel blocker, evidence from preclinical studies, comparisons with Semax, Selank, Cerebrolysin, and Dihexa, dosing protocols, and safety data.
Everything patients need to know about receiving peptides by air shipment: legality, storage on arrival, injection pain, drug testing, and oral bioavailability, with primary-source citations throughout.
A guide to peptides for hair loss, covering GHK-Cu, PTD-DBM, AnaGain, and topical peptide stacks, with dosing, evidence, and what to expect.
A guide covering peptide half-life science, how long common therapeutic peptides stay active, injection site pain, oral absorption limits, drug-test detection, and US legal status. Includes real doses, named trials, and sourced statistics.
A guide to peptide injection frequency covering dosing schedules for BPC-157, CJC-1295, ipamorelin, semaglutide, and more. Includes legal status, drug-test considerations, oral bioavailability, and pain management.
A guide to peptide purity testing standards, FDA 503A compounding rules, sterility requirements, and storage stability. Learn how to verify that your peptide therapy is safe, potent, and legally dispensed.
A guide to evaluating peptide sources, covering FDA status, compounding pharmacy standards, COA interpretation, injection safety, oral bioavailability, and drug-testing implications.
Learn exactly how temperature, light, pH, and oxidation degrade therapeutic peptides. Covers FDA 503A compounding rules, purity testing standards, sterility requirements, and step-by-step reconstitution storage protocols backed by primary clinical sources.
A guide to using peptides alongside GLP-1 medications like semaglutide. Covers legality, drug testing, injection technique, and oral delivery options with citations to primary clinical sources.
A clinical guide to combining peptides with testosterone replacement therapy (TRT), covering top stacks, mechanisms, dosing protocols, legal status in the US, drug testing, injection technique, and oral bioavailability.
A guide to specialty peptide therapies, including GLP-1 agonists, growth hormone secretagogues, GHK-Cu, and BPC-157. Covers mechanisms, dosing, clinical evidence, and how to choose the right peptide for your goals.
A guide to using peptide therapy alongside prescription medications, covering drug interactions, legal status, drug testing, injection technique, and oral bioavailability.
A deep dive into pinealon, the short peptide designed to support brain aging and cognitive function, plus comparisons with semax, selank, cerebrolysin, and dihexa.
A guide to PT-141 bremelanotide covering FDA-approved use for HSDD, off-label applications, dosing protocols, side effects, and comparisons with kisspeptin-10, therapeutic oxytocin, and DSIP.
Showing the first 60 matches among the loaded articles. Use the page links below to browse the complete library.